# Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With Asthma

> **NCT00238927** · PHASE4 · COMPLETED · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 150 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** inhaled fluticasone 750 mcg/day twice daily until 2 days without symptoms (maximum 15 consecutive days)

## Key facts

- **NCT ID:** NCT00238927
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-11
- **Primary completion:** 2005-09
- **Final completion:** 2005-09
- **Target enrollment:** 150 (—)
- **Last updated:** 2014-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238927, "Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With Asthma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00238927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*